Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy

Yi-Chi Yang,Qian Jiang,Ke-Ping Yang,Lingzhi Wang,Gautam Sethi,Zhaowu Ma

DOI: https://doi.org/10.1038/s41420-024-01799-6

2024-01-13

Cell Death Discovery

Abstract:Extracellular vesicles (EVs) have gained increasing recognition as significant regulators of intercellular communication in various physiological and pathological processes. These vesicles play a pivotal role in cancer progression by facilitating the transfer of diverse cargoes, including lipids, proteins, and nucleic acids. Regulated cell death (RCD), the orderly and autonomous death of cells, is controlled by a variety of biomacromolecules and, in turn, influences various biological processes and cancer progression. Recent studies have demonstrated that EV cargoes regulate diverse oncogenes and tumor suppressors to mediate different nonapoptotic forms of RCD, notably ferroptosis, pyroptosis, and necroptosis. Nevertheless, comprehensive exploration of EV-mediated nonapoptotic RCD forms in the context of cancer has not been performed. This review summarizes the progress regarding the biological functions and underlying mechanisms of EVs in mediating nonapoptotic RCD by delivery of cargoes to regulate tumor progression. Additionally, the review delves into the potential clinical applications of EV-mediated cell death and its significance in the areas of cancer diagnosis and therapy.

cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the potential clinical applications of Extracellular Vesicles (EVs) in cancer treatment, particularly through mediating non-apoptotic forms of Regulated Cell Death (RCD), including ferroptosis, pyroptosis, and necroptosis. Although existing studies have shown that EVs regulate various oncogenes and tumor suppressors by delivering different cargos, thereby mediating different forms of non-apoptotic RCD, comprehensive exploration of EV-mediated non-apoptotic RCD forms in the context of cancer is still insufficient. Therefore, this review aims to summarize the biological functions and potential mechanisms of EVs in mediating non-apoptotic RCD and to explore their clinical application potential in cancer diagnosis and treatment.

Specifically, the paper focuses on the following aspects:
1. **The role of EVs in non-apoptotic RCD**: Investigating how EVs influence tumor progression by delivering specific cargos, particularly in inducing or inhibiting ferroptosis, pyroptosis, and necroptosis.
2. **The relationship between non-apoptotic RCD and cancer treatment**: Analyzing how EV-mediated non-apoptotic RCD affects the response to cancer treatment, including chemotherapy resistance and radiotherapy resistance.
3. **The potential applications of EVs in cancer diagnosis and treatment**: Discussing how to utilize EV-mediated non-apoptotic RCD to develop new cancer diagnosis and treatment strategies.

Through these discussions, the paper hopes to provide new perspectives and strategies for cancer research and treatment.